e-drug
[Top] [All Lists]

[e-drug] MSF at AIDS 2012

E-DRUG: MSF at AIDS 2012
---------------------------

Dear All, 

I want to share with you the events and presentations MSF will be hosting 
and participating in during the upcoming 2012 International 
AIDS Conference in Washington, DC. Please find MSF's program below and 
also available in this website: http://aids2012.msf.org/

Join Doctors Without Borders/Medecins Sans Frontieres (MSF) at the 2012 
International AIDS Conference for these events and presentations.

Booth location: Exhibit Hall C, Booth 18
MSF report featured in Science Magazine 

HIV/AIDS Community Mobilization
MSF joins the mobilization in support of affordable ARVs treatment and 
against patent and trade practices that threaten HIV treatment scale-up.
+ Tuesday, July 24, 12:00, Mt. Vernon Square, K Street and 7th Street 

MSF-Sponsored Satellite Sessions

Proposals for a Global Innovation System that Responds to Patients Needs 
and Ensures both Innovation and Access (SUSA39)
Co-sponsored by Drugs for Neglected Diseases Initiative (DNDi) and Health 
GAP
Mariangela Simao, Nils Daulaire, Michelle Childs, Brook Baker, Rachel 
Cohen, Suerie Moon, Gregg Gonsalves, Blessina Kumar
+ Sunday, July 22, 13:30-15:30, Session Room 5 

Virological Monitoring: Bridging the North-South Divide (MOSA25)
Co-sponsored by UNITAID
Nathan Ford, Brenda Waning, Lihle Dlamini, Philippe Duneton, Jos Perriens, 
Eric Goemaere, Andrew Hill, Maurine Murtagh, Olivia Keiser, Teri Roberts
+ Monday, July 23, 18:30 - 20:30, Mini Room 5 

Putting Our Best Foot Forward: Getting the Best Treatment to the Most 
People Possible (TUSA10)
Nathan Ford, Morolake Odetoyinbo, Sharonann Lynch, Tom Decroo, Pedro Cahn, 
Leena Menghaney
+ Tuesday, July 24, 18:30 - 20:30, Session Room 2 

MSF-Sponsored Workshop

Overcoming Intellectual Property Barriers to Enable Access to Affordable 
Antiretrovirals: Pricing and Patent Toolkits and Sharing of Successful 
Strategies from Brazil, India and South Africa (THWS15)
Co-sponsored by Treatment Action Campaign (TAC) and UNDP
Judit Rius Sanjuan, Leena Menghaney, Felipe de Carvalho, Mandeep Dhaliwal, 
Nonkosi Khumalo, Michelle Childs, Marcela Vieira, María Lorena Di Giano, 
Arax Bozadjian
+ Thursday, July 26, 14:30 - 18:00, Mini Room 7 

Oral Abstract Sessions

Where Will the Money Come From? Challenges and Approaches to 
Sustainability (MOAE03)
Sharonann Lynch and others
+ Monday, July 23, 16:30 - 18:00, Session Room 4 

The Future of Affordable ART: Trends in Patents and Price (WEAE01)
+ Wednesday, July 25, 11:00 - 12:30, Session Room 7 

Young People, HIV and Sexual and Reproductive Health Services (WEAE04)
Sustaining Quality while Scaling-up Adolescent ART: Findings from 
Zimbabwe's Largest Adolescent Cohort.
Amir Shroufi
+ Wednesday, July 25, 16:30 - 18:00, Session Room 8 

TB Diagnostics: Innovating to Make an Impact (THAB01)
Implementing Xpert MTB/RIF in Rural Zimbabwe: Impact on Diagnosis of 
Smear-negative TB and Time-to-initiation of TB Treatment in Smear-negative 
Patients Co-infected with HIV.
Steven Van Den Broucke
+ Thursday, July 26, 11:00 - 12:30, Session Room 6 

Poster Discussions

Providing HIV Care in Floods, Violence and War (THPDE02)
Tom Ellman and others
+ Thursday, July 26, 13:00 - 14:00, Mini Room 3 

Beyond the Clinics: Novel Approaches to HIV Testing (THPDE03)
Towards Universal Awareness of HIV Status: a Systematic Review on Uptake 
of Home-based HIV Testing in Sub-Saharan Africa.
Nathan Ford
+ Thursday, July 26, 13:00 - 14:00, Mini Room 4 

Poster Presentations

+ Monday, July 23

Starting ART Early: Progress and Lessons from Zimbabwe's Largest Child 
Cohort (MOPE195)

Prevalence of Renal Impairment Among HIV-infected Antiretroviral Naïve 
Persons Eligible for ART in Rural Zimbabwe (MOPE091)

Similar ART Outcomes of Adolescents, Children and Adults: a Cohort Study 
from 9 African Countries (MOPE052)

+ Tuesday, July 24

Impact of a Mobile HIV/TB Service on Pre-ART Retention in Care among 
Migrant Farm Workers in Musina, South Africa (TUPE719)

Targeted Adherence Strategies for Provision of Antiretroviral Therapy 
(ART) to Migrant Farm Workers in Musina, South Africa (TUPE752)

+ Wednesday, July 25

A New Point-of-care HIV-1 Load Monitoring Assay for Low Resource Settings: 
Preliminary Evaluation (WEPE025)

HIV-positive Dependent Children in Rural Tete, Mozambique (WEPE720)

Prevalence and Incidence of HPV-infection, Cervical Abnormalities & Cancer 
in a Cohort of HIV-infected Women in Mumbai, India: 12-months Follow-up 
(WEPE081)

+ Thursday, July 26

Scaling-up of Triggered Viral Load in Rural Zimbabwe: Implications for 
Phasing out of D4T (THPE725)

Other Sessions With MSF Presenters

Workshop - Antiretroviral Therapy in Resource-Limited Settings: Progress 
and Evolving Challenges (TUWS11)
Beatriz Grinzstejn, Marco Antonio de Orvila Vitoria, James Hakim, Nathan 
Ford, Judith Currier, Myron Cohen, Jared Baeten, Nagalingeswaran 
Kumarasamy
+ Tuesday, July 24, 14:30 - 18:00, Mini Room 5 

Symposium - Meeting Capacity and Demand through Community-Based 
Interventions (THSY08)
Nathan Ford, Morolake Odetoyinbo, Wim Van Damme, Eric Goemaere, Eyerusalem 
Negussie, Address Malata, Kai Haldre
+ Thursday, July 26, 14:30 - 16:00, Global Village Session Room 1

Judit Rius Sanjuan
U.S. Manager of the Access Campaign
Medecins Sans Frontieres/ Doctors Without Borders (MSF)
333 Seventh Ave, 2nd Floor
New York, NY 10001 USA
Office: +1 212 655 3762 // Mobile: +1 917 331 9077
Email: judit.rius@newyork.msf.org 
<Prev in Thread] Current Thread [Next in Thread>
  • [e-drug] MSF at AIDS 2012, Judit Rius <=